Signs & Symptoms of BPH
Before visiting your doctor, write down a list of what you are experiencing as listed
here. While BPH symptoms range from mild to severe, the size of the prostate does
not necessarily correlate with the severity of the symptoms. As the prostate grows,
it can cause two primary sets of problems:
|
1
|
Obstructive symptoms related to the compression or obstruction of the urethra |
|
|
|
Feeling of incomplete bladder emptying
|
|
Delay and difficulty in initiating an urinary stream
|
|
Stopping and starting urination several times during voiding
|
|
Weak urinary stream
|
|
Dribbling at the end of urination
|
|
Pushing or straining while urinating
|
|
|
2
|
Irritative symptoms related to loss of bladder function and control |
|
|
|
Feeling of little warning when the urge of urination develops
|
|
Frequent urination with short intervals
|
|
Need to urinate during the night
|
|
Inability to hold back urine
|
|
Indication
UROXATRAL® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker
for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal
drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment.
This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate
machinery, or do any dangerous activity until you know how UROXATRAL will affect
you. This is especially important if you already have a problem with low blood pressure
or take medicines to treat high blood pressure.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for
a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a
treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract
infection, headache, and tiredness.
Please see UROXATRAL patient information.